Dr. Whalen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2150 Pennsylvania Ave NW
Ste 3-417
Washington, DC 20037Phone+1 202-741-3100Fax+1 202-741-3113
Summary
- Michael J. Whalen, MD is Assistant Professor of Urology with fellowship training and expertise in Urologic Oncology. Dr. Whalen’s specialty focus involves treatment of urological cancers, with expertise in both major open and minimally invasive surgery. His clinical interests include prostate cancer (including prostate MRI, MRI-ultrasound fusion biopsy and cryotherapy), bladder cancer (including blue-light cystoscopy and continent/incontinent urinary diversion), kidney cancer, testis cancer, adrenal cancer, ureteral cancer, robotic surgery with the DaVinci system (including prostatectomy, cystectomy, partial nephrectomy, and adrenalectomy) and laparoscopic surgery.
Dr. Whalen is actively involved in clinical outcomes research focusing on cancer of the prostate, bladder, and kidneys. He has published numerous original research articles in peer-reviewed journals, including Urologic Oncology, Urology Practice, Prostate, Journal of Laparoendoscopic & Advanced Surgical Techniques, and BJU International. His research interests include robotic surgery techniques, optimization of pathologic reporting of urological cancers, and multiparametric magnetic resonance imaging (mp-MRI) and its role in prostate cancer management—active surveillance, post-treatment biochemical recurrence, focal ablation, and comparison to/integration with commercially-available serum-based and tissue-based genomic assays.
Dr. Whalen has presented at numerous conferences in the US and internationally, including the American Urological Association (AUA) National Conference, the AUA New York Section Ferdinand C. Valentine Medal & Resident Essay Meeting, the 2016 World Cancer Congress in Shanghai, China, and the 2014 AUA National Chief’s Debate, which he won as a representative of the New York Section. He is a member of the American Urological Association. He has reviewed articles for Current Urology and served as a reviewer/statistical consultant for the Journal of Urology.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 2009 - 2014
- New York Presbyterian HospitalInternship, Transitional Year, 2008 - 2009
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2008
Certifications & Licensure
- VA State Medical License 2020 - 2026
- MD State Medical License 2018 - 2025
- DC State Medical License 2016 - 2024
- CT State Medical License 2015 - 2017
- NY State Medical License 2009 - 2015
- American Board of Urology Urology
Awards, Honors, & Recognition
- National Chief Resident Debate Winner American Urological Association, 2014
- Chief Resident Debate runner up New York Section of the American Urological Association, 2014
- Valentine Essay Contest Manuscript Presentation New York Section of the American Urological Association, 2013-2014
Publications & Presentations
PubMed
- 1 citationsTrends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder.Charles Klose, Olivia Gordon, Andrew Sparks, Michael Whalen
Clinical Genitourinary Cancer. 2023-12-01 - 8 citationsNeoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology.James Lin, Michael J. Whalen, Dara Holder, Gregory W. Hruby, G. Joel DeCastro
The Canadian Journal of Urology. 2013-04-01 - 1 citationsUnveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatin-chemotherapy: a Tempus gene analysis-based case repo...Christian M Farag, Elena K Johnston, Ryan M Antar, Shaher G Issa, Qasim Gadiwalla
Frontiers in Oncology. 2023-01-01
Authored Content
- Lymph Node Yield During Radical Prostatectomy Does Not Impact Rate of Biochemical Recurrence in Patients with Seminal Vesicle Invasion and Node-Negative DiseaseApril 2018
- Lymph Node Yield During Radical Prostatectomy Does Not Impact Rate of Biochemical Recurrence in Patients with Seminal Vesicle Invasion and Node-Negative DiseaseApril 2018
- Lymph Node Yield During Radical Prostatectomy Does Not Impact Rate of Biochemical Recurrence in Patients with Seminal Vesicle Invasion and Node-Negative DiseaseApril 2018
Press Mentions
- Close Surgical Margins Raise Risk of Prostate Cancer ReturnAugust 14th, 2015
- AI-Based Predictive Model Could Spare Use of Prostate Cancer ADTAugust 1st, 2023
- Defense Secretary Lloyd Austin's Diagnosis Raises Questions About Prostate Cancer Screenings — and Why They Aren't Recommended for All MenJanuary 13th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: